ArticleJournal of medical virology2022

Neutralizing antibodies to SARS-CoV-2 variants of concern including Delta and Omicron in subjects receiving mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines.

George Fei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.